Â鶹´«Ã½É«ÇéƬ

Glioblastoma multiforme is a type of cancer that develops in the brain. Aggressive and difficult to treat, tumors respond to few drugs, and most patients are treated with methods developed about 20 years ago. Kyle Nguyen, a second-year Ph.D. student in ’s laboratory at Oregon State University, has been looking for a new way to target these tumors. He will present on Friday, 3–3:15 p.m. EDT, at the 2021 ASBMB Annual Meeting.

Courtesy of Kyle Nguyen

Kyle Nguyen in one of the Franco lab’s tissue culture rooms.

In broad terms, the Franco lab is interested in the role of oxidative stress in diseases of the nervous system. Oxidative stress is a chemical imbalance inside cells that leads to an accumulation of oxidants that damage healthy cells. It has been linked to , including cancer. The lab studies the role of oxidants in the development and growth of tumors of the nervous system.

Franco lab

A confocal microscope image of actin polymerization within glioblastoma cells. Actin is in red, cell nuclei are in blue.

is the most powerful oxidant produced in cancer cells and in cells associated with other diseases. When peroxynitrite reacts with proteins it causes oxidative changes that can negatively affect the way the proteins work in the cells. “As far as we know, these are permanent chemical changes,” Nguyen said.

The lab is interested in tyrosine nitration, one of the changes mediated by peroxynitrite. Tyrosine nitration is virtually undetectable in normal tissues, Nguyen explained, so drugs that target nitrated proteins would not affect healthy cells. His project looked at tyrosine nitration of a protein called heat shock protein 90, or . Nitrated Hsp90 promotes the survival of tumor cells, and this role is mediated by nitration of tyrosine residues within this protein.

In his work, Nguyen shows that tyrosine nitration supports the survival and migration of glioblastoma cells and thus is important for tumor development, and that nitrated Hsp90 may play more than one role in these tumors. Non-tumor cells do not have nitrated Hsp90 and tumor cells do, so targeting nitrated Hsp90 or other nitrated proteins could selectively kill tumor cells with few side effects.